Skip to content
PubMed This is a summary of 68 peer-reviewed journal articles Updated
Nephrology

Fanconi Renotubular Syndrome 1: A Patient Guide

At a Glance

Fanconi renotubular syndrome 1 is a rare inherited kidney disorder caused by a GATM gene change. Genetic testing can confirm it after mineral losses, bone symptoms, or problems with growth raise concern. Treatment uses phosphate and active vitamin D, with checks of bone health and kidney function.

Fanconi Renotubular Syndrome 1 (FRTS1) is a rare genetic condition that fundamentally changes how your kidneys manage the body’s “building blocks.” In a healthy kidney, tiny structures called proximal tubules act as recycling centers, reclaiming vital minerals, sugars, and proteins before they can be lost in the urine. For those with FRTS1, a mutation in the GATM gene causes proteins to clump together within the energy-producing parts of these tubule cells, making it difficult for them to do their job [1]. As a result, the kidneys begin to “leak” essential substances like phosphate, potassium, and bicarbonate that the body needs to maintain strong bones and steady energy levels [2].

Understanding this diagnosis starts with clearing up a very common point of confusion: although the names are similar, Fanconi Renotubular Syndrome 1 is entirely distinct from Fanconi Anemia. While Fanconi Anemia is a complex blood and DNA repair disorder, FRTS1 is specifically a disorder of the kidney tubules and bone metabolism [1]. Because the symptoms—such as bone pain, bowing of the legs, or growth delays—often mirror other common conditions like simple Vitamin D deficiency, getting to the right answer often requires specialized genetic testing to confirm the GATM variant [3]. Knowing exactly which condition you are managing is the first step toward building a targeted care plan that protects your long-term health.

Living with FRTS1 is largely a journey of balance and consistent support. Since there is currently no way to “fix” the underlying genetic mutation, treatment focuses on replacing the specific minerals and nutrients the kidneys are losing to reduce deficiency-related complications [4]. This involves an individualized daily routine of supplements, such as oral phosphate and active Vitamin D, alongside regular monitoring of your blood and urine levels to ensure your bones stay strong and your metabolism stays balanced. While this daily management is highly effective for protecting bone health, its long-term effect on preventing GATM-related chronic kidney disease (CKD) progression is still being studied [2].

Although FRTS1 is exceptionally rare, you do not have to navigate it alone. Because the condition’s progression is highly variable, having a dedicated care team—including a nephrologist and a geneticist—is essential for tailoring treatment to your specific needs. Research into GATM-associated disorders is expanding every year. You are the most important member of your care team, and being informed is your greatest tool in protecting your or your child’s future [5].

Common questions in this guide

What is Fanconi renotubular syndrome 1?
Fanconi renotubular syndrome 1 (FRTS1) is a rare inherited kidney condition caused by a change in the GATM gene. The kidney’s proximal tubules, which normally reclaim useful substances, let minerals and other substances escape into urine, affecting bone health, growth, and body chemistry.
Is Fanconi renotubular syndrome 1 the same as Fanconi anemia?
No. FRTS1 is a disorder of the kidney tubules that can lead to mineral loss and bone problems, whereas Fanconi anemia is a different disorder involving blood cells and DNA repair. The similar names describe separate conditions.
What symptoms might a child with FRTS1 have?
Symptoms can include bone pain, bowed legs, and delayed growth. They may resemble other problems, including vitamin D deficiency, so symptoms alone cannot confirm FRTS1.
How is FRTS1 diagnosed?
Doctors use blood and urine results, the clinical picture, and specialized genetic testing. Finding a disease-causing GATM variant can confirm the diagnosis and help distinguish FRTS1 from other conditions with similar symptoms.
How is Fanconi renotubular syndrome 1 treated?
There is currently no treatment that repairs the underlying GATM mutation. Care usually focuses on replacing lost minerals, including phosphate, and providing active vitamin D, with doses adjusted using regular blood and urine monitoring.
Which specialists should care for someone with FRTS1?
A nephrologist can manage kidney-related mineral losses and monitor kidney function, while a medical geneticist can help confirm the GATM-related diagnosis and discuss inherited disease. A coordinated care team may also monitor bone health, growth, and treatment needs over time.
Can FRTS1 affect kidney function over time?
FRTS1 progression can vary, and the long-term effect of replacement treatment on GATM-related chronic kidney disease progression is still being studied. Regular kidney function checks help the care team watch for changes and adjust management.

Get notified when new evidence is published on Fanconi renotubular syndrome 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (5)
  1. 1

    Complex phenotype in Fanconi renotubular syndrome type 1: Hypophosphatemic rickets as the predominant presentation.

    Li CY, Sun Y, Guo WC, et al.

    Clinica chimica acta; international journal of clinical chemistry 2024; (561()):119812 doi:10.1016/j.cca.2024.119812.

    PMID: 38876250
  2. 2

    Genetic Screening of Patients With Inherited Fanconi Syndrome.

    Inoki Y, Sakakibara N, Yamamoto A, et al.

    Kidney international reports 2026; (11(7)):106576 doi:10.1016/j.ekir.2026.106576.

    PMID: 42282999
  3. 3

    Inherited Fanconi renotubular syndromes: unveiling the intricacies of hypophosphatemic rickets/osteomalacia.

    Ragate DC, Memon SS, Karlekar M, et al.

    Journal of bone and mineral metabolism 2024; (42(2)):155-165 doi:10.1007/s00774-023-01490-3.

    PMID: 38310177
  4. 4

    Fanconi Syndrome.

    Foreman JW

    Pediatric clinics of North America 2019; (66(1)):159-167 doi:10.1016/j.pcl.2018.09.002.

    PMID: 30454741
  5. 5

    Genetic Testing in the Pediatric Nephrology Clinic: Understanding Families' Experiences.

    Nevin SM, McLoone J, Wakefield CE, et al.

    Journal of pediatric genetics 2022; (11(2)):117-125 doi:10.1055/s-0040-1721439.

    PMID: 35769952

This page provides general information about Fanconi renotubular syndrome 1 and does not replace medical advice. A nephrologist and geneticist should interpret your or your child's test results and treatment plan.